Sponsor pipeline

Maria Sklodowska-Curie National Research Institute of Oncology clinical trial pipeline

Get alerts when Maria Sklodowska-Curie National Research Institute of Oncology's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 1 stopped, 0 with notable changes, 0 with minor changes only.

  1. Stopped

    Trial terminated

    Also in this update: Final enrollment: 49 participants (planned 124); Primary completion date changed from estimate of Dec 31, 2025 to Apr 21, 2026

    Maria Sklodowska-Curie National Research Institute of OncologyPhase 2 NCT04920968 Registry history

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
9
Phase 3
1
Not charted: 5 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 13

Head & Neck Cancer (3) · Breast Cancer (2) · Acute Myeloid Leukemia (AML) (1) · Cervical Cancer (1) · Endometrial Cancer (1) · Heart Disease (1) · Kidney Cancer (1) · Leukemia (1) · Melanoma (1) · Myelodysplastic Syndromes (MDS) (1)

Get alerts when Maria Sklodowska-Curie National Research Institute of Oncology's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free